Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells

E. Peverelli; E. Giardino; D. Treppiedi; E. Vitali; V. Cambiaghi; M. Locatelli; G. B. Lasio; A. Spada; A. G. Lania; G. Mantovani

doi:10.1210/en.2014-1063

Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells

E. Peverelli, E. Giardino, D. Treppiedi, E. Vitali, V. Cambiaghi, M. Locatelli, G. B. Lasio, A. Spada, A. G. Lania, G. Mantovani

Research output: Contribution to journal › Article

Abstract

Somatostatin receptor type 2 (SST2) is the main pharmacological target of medical therapy for GH-secreting pituitary tumors, but molecular mechanisms regulating its expression and signaling are largely unknown. The aim of this study was to investigate the role of cytoskeleton protein filamin A (FLNA) in SST2 expression and signaling in somatotroph tumor cells. We found a highly variable expression of FLNA in human GH-secreting tumors, without a correlation with SST2 levels. FLNA silencing in human tumoral cells did not affect SST2 expression and localization but abolished the SST2-induced reduction of cyclin D1 (-37% ± 15% incontrol cells, P

Original language	English
Pages (from-to)	2932-2941
Number of pages	10
Journal	Endocrinology
Volume	155
Issue number	8
DOIs	https://doi.org/10.1210/en.2014-1063
Publication status	Published - 2014

ASJC Scopus subject areas

Endocrinology

Access to Document

10.1210/en.2014-1063

Fingerprint Dive into the research topics of 'Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells'. Together they form a unique fingerprint.

Cite this

Peverelli, E., Giardino, E., Treppiedi, D., Vitali, E., Cambiaghi, V., Locatelli, M., Lasio, G. B., Spada, A., Lania, A. G., & Mantovani, G. (2014). Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells. Endocrinology, 155(8), 2932-2941. https://doi.org/10.1210/en.2014-1063

Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells. / Peverelli, E.; Giardino, E.; Treppiedi, D.; Vitali, E.; Cambiaghi, V.; Locatelli, M.; Lasio, G. B.; Spada, A.; Lania, A. G.; Mantovani, G.

In: Endocrinology, Vol. 155, No. 8, 2014, p. 2932-2941.

Research output: Contribution to journal › Article

Peverelli, E, Giardino, E, Treppiedi, D, Vitali, E, Cambiaghi, V, Locatelli, M , Lasio, GB, Spada, A, Lania, AG & Mantovani, G 2014, 'Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells', Endocrinology, vol. 155, no. 8, pp. 2932-2941. https://doi.org/10.1210/en.2014-1063

Peverelli, E. ; Giardino, E. ; Treppiedi, D. ; Vitali, E. ; Cambiaghi, V. ; Locatelli, M. ; Lasio, G. B. ; Spada, A. ; Lania, A. G. ; Mantovani, G. / Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells. In: Endocrinology. 2014 ; Vol. 155, No. 8. pp. 2932-2941.

@article{9b96dcdd99d44e0c9ae2b108cec399e1,

title = "Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells",

abstract = "Somatostatin receptor type 2 (SST2) is the main pharmacological target of medical therapy for GH-secreting pituitary tumors, but molecular mechanisms regulating its expression and signaling are largely unknown. The aim of this study was to investigate the role of cytoskeleton protein filamin A (FLNA) in SST2 expression and signaling in somatotroph tumor cells. We found a highly variable expression of FLNA in human GH-secreting tumors, without a correlation with SST2 levels. FLNA silencing in human tumoral cells did not affect SST2 expression and localization but abolished the SST2-induced reduction of cyclin D1 (-37% ± 15% incontrol cells, P",

author = "E. Peverelli and E. Giardino and D. Treppiedi and E. Vitali and V. Cambiaghi and M. Locatelli and Lasio, {G. B.} and A. Spada and Lania, {A. G.} and G. Mantovani",

year = "2014",

doi = "10.1210/en.2014-1063",

language = "English",

volume = "155",

pages = "2932--2941",

journal = "Endocrinology",

issn = "0013-7227",

publisher = "The Endocrine Society",

number = "8",

}

TY - JOUR

T1 - Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells

AU - Peverelli, E.

AU - Giardino, E.

AU - Treppiedi, D.

AU - Vitali, E.

AU - Cambiaghi, V.

AU - Locatelli, M.

AU - Lasio, G. B.

AU - Spada, A.

AU - Lania, A. G.

AU - Mantovani, G.

PY - 2014

Y1 - 2014

N2 - Somatostatin receptor type 2 (SST2) is the main pharmacological target of medical therapy for GH-secreting pituitary tumors, but molecular mechanisms regulating its expression and signaling are largely unknown. The aim of this study was to investigate the role of cytoskeleton protein filamin A (FLNA) in SST2 expression and signaling in somatotroph tumor cells. We found a highly variable expression of FLNA in human GH-secreting tumors, without a correlation with SST2 levels. FLNA silencing in human tumoral cells did not affect SST2 expression and localization but abolished the SST2-induced reduction of cyclin D1 (-37% ± 15% incontrol cells, P

AB - Somatostatin receptor type 2 (SST2) is the main pharmacological target of medical therapy for GH-secreting pituitary tumors, but molecular mechanisms regulating its expression and signaling are largely unknown. The aim of this study was to investigate the role of cytoskeleton protein filamin A (FLNA) in SST2 expression and signaling in somatotroph tumor cells. We found a highly variable expression of FLNA in human GH-secreting tumors, without a correlation with SST2 levels. FLNA silencing in human tumoral cells did not affect SST2 expression and localization but abolished the SST2-induced reduction of cyclin D1 (-37% ± 15% incontrol cells, P

UR - http://www.scopus.com/inward/record.url?scp=84904985820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904985820&partnerID=8YFLogxK

U2 - 10.1210/en.2014-1063

DO - 10.1210/en.2014-1063

M3 - Article

C2 - 24828612

AN - SCOPUS:84904985820

VL - 155

SP - 2932

EP - 2941

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 8

ER -